Philips today announced the first implant of its Duo venous stent system following FDA premarket approval. Duo, an implantable medical device, treats symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). Amsterdam-based Philips added Duo to its portfolio when it acquired Vesper Medical in 2021. On June … [Read more...] about Philips launches Duo venous stent system with FDA approval
Philips
Philips prices $758.6M offering, expands access to intracardiac echocardiography
Philips announced that it priced an offering worth $758.6 million (€700 million) in fixed-rate notes. The notes, due in 2032, fall under the Philips European Medium Term Note (EMTN) program. Issuance will have a debt-neutral effect, with proceeds earmarked for the repayment of debt in 2024 and 2025. This follows last year's pricing of a $546.2 … [Read more...] about Philips prices $758.6M offering, expands access to intracardiac echocardiography
Philips announces positive three-year results for its Tack endovascular system
Philips this week announced the latest results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. Amsterdam-based Royal Philips designed Tack to provide a sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI), a severe stage of peripheral arterial … [Read more...] about Philips announces positive three-year results for its Tack endovascular system
Philips to buy Vesper Medical and its advanced venous stent portfolio
Royal Philips announced today that it will acquire Vesper Medical, a Wayne, Pennsylvania–based maker of minimally-invasive peripheral vascular devices. The financial terms of the deal were not disclosed. The purchase will enable the Dutch medtech giant to expand its diagnostic and therapeutic devices portfolio with advanced venous stents. The … [Read more...] about Philips to buy Vesper Medical and its advanced venous stent portfolio
Philips treats first patient with 3D intracardiac echocardiography catheter
Royal Philips (NYSE:PHG) announced today that it treated the first patient with its real-time, 3D intracardiac echocardiography (ICE) catheter. Dr. Mohamad Adnan Alkhouli performed a left atrial appendage occlusion (LAAO) procedure with Philips’ VeriSight Pro platform at the Minneapolis-based Mayo Clinic. Get the full story at our sister site, … [Read more...] about Philips treats first patient with 3D intracardiac echocardiography catheter
The top 10 catheter innovations of 2020
As the COVID-19 pandemic took over the world in 2020, medical device companies continued to showcase new catheter innovations. Throughout 2020, we saw FDA clearances, approvals and product launches for a variety of catheter-based technologies, including renal denervation systems, heart failure treatment catheters, mechanical thrombectomy systems … [Read more...] about The top 10 catheter innovations of 2020
Philips touts post-stent imaging study results
Royal Philips (NYSE:PHG) announced today that one-year results of its Define PCI study that reported improved outcomes and less recurrent angina. The Define PCI study assessed the level of residual ischemia found in patients following a percutaneous coronary intervention (PCI) using a blinded instant wave-free ratio (iFR) pullback measurement, … [Read more...] about Philips touts post-stent imaging study results
